By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Edge Therapeutics 

NJIT-EDC Biotechnology Incubator
139 South Street, Suite 102
New Providence  New Jersey  07974  U.S.A.
Phone: 800-208-EDGE Fax: 800-208-3433



Company News
Edge Therapeutics, Evonik Industries Granted EG-1962 Composition Of Matter Patent 9/30/2014 10:20:19 AM
Edge Therapeutics Grabs $10 Million Venture Loan 9/8/2014 6:48:47 AM
Edge Therapeutics Initiates Enrollment Of Second Cohort In Phase 1/2 NEWTON Study Of EG-1962 For Improvement Of Outcome After Ruptured Brain Aneurysm 6/5/2014 9:49:55 AM
Edge Therapeutics Expands Senior Management Team And Opens New Headquarters To Support Continued Growth 4/8/2014 9:39:57 AM
Edge Therapeutics Enrolls First Patient in Phase 1/2 NEWTON Study of EG-1962 for Prevention of Delayed Cerebral Ischemia 10/31/2013 12:05:01 PM
Edge Therapeutics Elects Robert J. Spiegel, MD to Board of Directors 9/10/2013 6:44:10 AM
Vasospasm 2013 Conference Features Oral Presentation of Edge Therapeutics’ EG-1962 7/12/2013 8:07:04 AM
Edge Therapeutics Reports Positive Early Clinical Experience With EG-1962 to Prevent Serious Complications After Brain Hemorrhage 6/27/2013 10:36:36 AM
FDA Accepts IND Application for Edge Therapeutics' EG-1962 (nimodipine microparticles) 6/10/2013 10:05:49 AM
Edge Therapeutics Banks $18 Million 6/4/2013 6:56:51 AM